NCT07097571View on ClinicalTrials.gov

Suprascapular Nerve Block in the Management of Patients Diagnosed With Adhesive Capsulitis

NAActive, not recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 26, 2025

Primary Completion Date

July 26, 2026

Study Completion Date

August 26, 2026

Conditions
Adhesive Capsulitis of the ShoulderSuprascapular Nerve Block
Interventions
PROCEDURE

Glenohumeral Joint Injection and Suprascapular Nerve Block

An intra-articular injection into the glenohumeral joint will be performed using 4 cc of normal saline and 1 cc of betamethasone. Additionally, a suprascapular nerve block will be administered with 5 cc of lidocaine(%2).

Trial Locations (1)

Unknown

Istanbul University - Cerrahpasa, Istanbul

All Listed Sponsors
lead

Istanbul University - Cerrahpasa

OTHER

NCT07097571 - Suprascapular Nerve Block in the Management of Patients Diagnosed With Adhesive Capsulitis | Biotech Hunter | Biotech Hunter